Diagnosis of probable Alzheimer type according to NINCDS-ADRDA criteria and K-MMSE score of 18–26 at visit 1
Change from the baseline in ADAS-Cog
Change from the baseline in S-IADL, K-MMSE, CGA-NPI, and so forth
24 months
2017-05
2021-12 (recruiting)
Korea
indicates the number of enrollment; AD: Alzheimer’s disease; ADAS-CCGIC: Alzheimer’s Disease Cooperative Study Clinician’s Global Impression of Change; ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale; CGA-NPI: Caregiver-Administered Neuropsychiatric Inventory; DSM: Diagnostic and Statistical Manual of Mental Disorders; hUCB-MSC: human umbilical cord blood-derived mesenchymal stem cell; K-MMSE: Korean version of Mini-Mental State Evaluation; MMSE: Mini-Mental State Evaluation; NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; S-IADL: Seoul-Instrumental Activities of Daily Living. is the follow-up study of clinical trial number 02054208.